SCHEMBL19475174

SCHEMBL19475174

Nc1ccccc1-c1cccnc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
HSD17B10 Q99714 1/20 0.41
IDO1 P14902 5/20 0.40
HSP90AA1 P07900 2/20 0.40
HSP90AB1 P08238 2/20 0.40
PSMB5 P28074 1/20 0.40
ATAD2 Q6PL18 1/20 0.40
ALOX15 P16050 2/20 0.39
TSHR P16473 1/20 0.39
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
PI4KA P42356 1/20 0.38
PI4K2B Q8TCG2 1/20 0.38
PI4K2A Q9BTU6 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
KDM4E B2RXH2 2/20 0.37
PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30285138 1.00 ALDH1A1 (0.54) ALDH1A1L3MBTL1HSD17B10IDO1HSP90AA1
SCHEMBL2592408 0.84 TDP1 (0.44) ALDH1A1L3MBTL1HSP90AA1ALOX15TSHR
SCHEMBL7086560 0.81 MAP4K4 (0.42) ALDH1A1L3MBTL1HSD17B10IDO1HSP90AA1
SCHEMBL15784149 0.81 KDM4E (0.38) ALDH1A1L3MBTL1IDO1HSP90AA1HSP90AB1
SCHEMBL105350 0.80
SCHEMBL30046325 0.78 ALDH1A1 (0.59) ALDH1A1L3MBTL1HSD17B10IDO1ATAD2
SCHEMBL28545758 0.78 RIPK1 (0.47) ALDH1A1L3MBTL1HSD17B10IDO1ALOX15
SCHEMBL29594708 0.78 RIPK1 (0.47) ALDH1A1L3MBTL1HSD17B10IDO1ALOX15
SCHEMBL28907433 0.78 ALDH1A1 (0.59) ALDH1A1L3MBTL1HSD17B10IDO1ATAD2
Methane SCHEMBL28426734 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311813-B Palladium-catalyzed meta-C-H functionalized universal ligands 斯克利普斯研究院 2023-02-28 CN disclosed
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 US disclosed
WO-2017184589-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS AHR, PAH, DOHH ALDH1A1 208/4885L3MBTL1 3987/4885HSD17B10 562/4885
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates PAH, AHR, DDC ALDH1A1 121/4885L3MBTL1 4735/4885HSD17B10 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.